Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...
  • The Global Pharmaceutical Industry

    The Demise and the Path to Recovery

    Series series Routledge Advances in Management and Business Studies
    The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard to discern. The prices the industry charges for its prescription drugs have escalated at four to five times the cost-of-living increases during the past two decades and have reached a point where 30% of Americans must choose between ... Read more

    $59.99 USD

People who read this also enjoyed

  • The Truth About the Drug Companies

    How They Deceive Us and What to Do About It

    by Marcia Angell ...
    During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless ... Read more

    $11.99 USD

  • The Cost Disease: Why Computers Get Cheaper and Health Care Doesn't

    The exploding cost of health care in the United States is a source of widespread alarm. Similarly, the upward spiral of college tuition fees is cause for serious concern. In this concise and illuminating book, well-known economist William J. Baumol explores the causes of these seemingly intractable problems and offers a surprisingly simple explanation. Baumol identifies the "cost disease" as a ... Read more

    $21.59 USD

  • Side Effects

    How Our Healthcare Lost Its Way – And How We Fix It

    by David Haslam ...
    In the shadow of the pandemic , how do we make a healthcare system that is affordable, effective and fair? With a single drug in the UK currently costing £ 340,000 per patient per year, or a gene therapy in the USA being costed at $1.2million, who should get such treatments, and how can we begin to afford them? Should we all be entitled to timely mental health therapy? How should we care for our ... Read more

    $11.99 USD or Free with Kobo Plus

  • Sickening

    How Big Pharma Broke American Health Care and How We Can Repair It

    by John Abramson ...
    The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health.The United States spends an excess $1.5 trillion annually on health care compared to other wealthy countries—yet the amount of time that Americans live in good health ranks a lowly 68th in the world. At the heart of ... Read more

    Was $11.99 USD Now $5.99 USD

  • Deadly Monopolies

    The Shocking Corporate Takeover of Life Itself--And the Consequences for Your Health and Our Medical Future.

    From the award-winning author of Medical Apartheid, an exposé of the rush to own and exploit the raw materials of life—including yours.Think your body is your own to control and dispose of as you wish? Think again. The United States Patent Office has granted at least 40,000 patents on genes controlling the most basic processes of human life, and more are pending. If you undergo surgery in many ... Read more

    $4.99 USD

  • Principles of Pharmaceutical Marketing

    Principles of Pharmaceutical Marketing, Third Edition offers the perspectives of both those who teach and those who practice pharmaceutical marketing. This reflects the need for and the effort to provide the most relevant “real world” approach to this complex and fascinating field. This text is designed for undergraduate students in pharmacy whose background in marketing is limited, those actually ... Read more

    $61.99 USD

  • Private Profits versus Public Policy

    The Pharmaceutical Industry and the Canadian State

    by Joel Lexchin ...
    The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren’t the interests of the public supposed to supersede the pursuit of private profit?In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy ... Read more

    $31.99 USD

  • Bigger Government

    The Future of Government Expenditure in Advanced Economies

    by Marc Robinson ...
    FINANCIAL TIMES BEST ECONOMICS BOOKS OF 2020Advanced nations are headed for a new era of bigger government, with government expenditure set to increase enormously over the next three decades. In all advanced economies, health spending will be driven irresistibly upward by the costs of precision medicine and other new technologies, and the need to repair weaknesses highlighted by the coronavirus ... Read more

    $12.99 USD or Free with Kobo Plus

  • Pharmaceutical Market Access in Developed Markets

    Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization.It covers a group of activities intended to provide access to the appropriate medicine for the ... Read more

    $10.99 USD or Free with Kobo Plus

  • The Cure

    How Capitalism Can Save American Health Care

    by David Gratzer ...
    We are surrounded by medical miracles: polio has been eradicated; childhood leukemia is now treatable; death by cardiovascular disease has declined by two-thirds in the last fifty years. Yet while American medicine has never been better, angst over American health care has never been greater. Why is American health care such a mess? In this path-breaking book--Nobel laureate Milton Friedman calls ... Read more

    $12.99 USD

  • From Breakthrough to Blockbuster

    The Business of Biotechnology

    Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these ... Read more

    $25.69 USD